<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="employed AVARDA to analyze VirScan data from a cohort of" exact="encephalitis" post="patients with either known viral infections or undiagnosed etiologies."/>
 <result pre="5, and 6, thereby improving the rate of diagnosing viral" exact="encephalitis" post="in this cohort by 62.5%. We further assessed AVARDA’s"/>
 <result pre="Supplemental Table 1. Nucleic acid testing had previously diagnosed a" exact="herpes simplex" post="virus 1 (HSV1) infection in this individual, consistent with"/>
 <result pre="represent alphaherpesvirus-associated proteins. Notably, antibodies from this patient with HSV1" exact="encephalitis" post="enriched 22 peptides designed to represent HSV2, highlighting the"/>
 <result pre="Download powerpoint Table 1. Summary of AVARDA results from the" exact="encephalitis" post="cohort. The ‘virus’ column indicates the identified viral infection"/>
 <result pre="course of its analysis. AVARDA for unbiased diagnosis of viral" exact="encephalitis" post="The AVARDA framework used to analyze Pt1’s longitudinal data"/>
 <result pre="analysis of 38 encephalitic patients not suspected of having viral" exact="encephalitis" post="resulted in only a single significant infection (Pt14). Interestingly,"/>
 <result pre="diabetes) 16 , neurodegenerative disease (e.g., Alzheimer’s disease) 17 ," exact="cancer" post="(e.g., cervical cancer) 18 and allergic disease (e.g., asthma)"/>
 <result pre="respiratory syncytial virus, coronavirus, and astrovirus infections. Antibodies directed against" exact="measles" post="and rubella, but not mumps, were detected in the"/>
 <result pre="step. Pt17, previously with no AVARDA-detected infections, exhibited nine increasing" exact="rubella" post="virus peptide enrichments and six increasing herpesvirus 8 peptide"/>
 <result pre="Clinical serological analysis detected a slight, though insignificant, increase in" exact="rubella" post="virus antibody titer between timepoints, highlighting the potential loss"/>
 <result pre="Points in blue represent enriched peptides. Enriched peptides associated with" exact="rubella" post="are additionally marked in red. &amp;lt;;strong&amp;gt;;(B)&amp;lt;;/strong&amp;gt;; Network graph representation"/>
 <result pre="Points in blue represent enriched peptides. Enriched peptides associated with" exact="rubella" post="are additionally marked in red. (B) Network graph representation"/>
 <result pre="and establish an archive of biological tissues from patients with" exact="encephalitis" post="and CNS infections that can be utilized for future"/>
 <result pre="data are also printed to file. Clinical Antibody Tests All" exact="herpes simplex" post="virus, varicella zoster virus, cytomegalovirus and Epstein-Barr virus antibody"/>
 <result pre="matrix. L- F.W., D.E.A., L.V., K.T. and W.C provided the" exact="encephalitis" post="cohort samples, conducted sample selection, preliminary testing and provided"/>
 <result pre="dominate the human B cell response against 2009 pandemic H1N1" exact="influenza" post="virus infection. J. Exp. Med. jem.20101352 ( 2011). doi:"/>
 <result pre="↵ Armangue, T. , Leypoldt, F. &amp;amp;; Dalmau, J. Auto-immune" exact="encephalitis" post="as differential diagnosis of infectious encephalitis. Curr. Opin. Neurol."/>
 <result pre="B. et al. PhIP-Seq characterization of autoantibodies from patients with" exact="multiple sclerosis," post="type 1 diabetes and rheumatoid arthritis. J. Autoimmun. 43,"/>
 <result pre="autoantibodies from patients with multiple sclerosis, type 1 diabetes and" exact="rheumatoid arthritis." post="J. Autoimmun. 43, 1– 9 ( 2013). OpenUrl CrossRef"/>
 <result pre="et al. Systematic autoantigen analysis identifies a distinct subtype of" exact="scleroderma" post="with coincident cancer. Proc. Natl. Acad. Sci. U. S."/>
</results>
